In mammals, billions of cells are turned over daily in a continuous succession of cell death and replacement. This occurs as part of either routine homeostasis (aged or excess cells) or after acute injury. These cells die usually by the process of apoptosis and are rapidly removed by neighboring or recruited phagocytes1. Unlike phagocytosis of pathogens, apoptotic cell clearance actively induces immunosuppressive signaling2. Very few apoptotic cells can usually be detected, even in the tissues with high cellular turnover, due to the quick removal by phagocytes3. The clearance of apoptotic cells critically depends on the function of phagocyte engulfment receptors, which recognize the apoptotic cell "eat me" signals and mediate their removal4. Defects in engulfment are linked to the development of autoimmunity in mice and humans, presumably because of the secondary necrosis of the dying cells and the release of their cellular contents, which activate the adaptive immune response specific to self antigens5. The efficiency of apoptotic cell clearance appears to also be diminished during aging and obesity6, 7.
In addition to homeostatic cellular turnover, millions of cells die during inflammatory conditions, when phagocyte clearance of the injured cells and tissue infiltrating neutrophils contribute to the resolution of inflammation2. Acute resolving inflammation is necessary for preservation of tissue function after an insult, such as myocardial infarction8. Failures in resolving inflammation lead to chronic inflammation, tissue damage and development of pathologies, including cardiovascular disease1, 9. This is exemplified in atherosclerosis, where the continual presence of lipoproteins in the arterial intima, recruitment of inflammatory macrophages and the accumulation of non-phagocytosed apoptotic cells are linked to the generation of an inflammatory state10, 11. In animal models of atherosclerosis, impaired clearance of dying cells due to the lack of engulfment receptors MER, LRP1 or TG2 on phagocytes, or deficiency of the bridging molecule MFG-E8 that binds to apoptotic cells and facilitates phagocytic uptake, leads to larger atherosclerotic lesions and expanded areas of necrosis12–15.
Despite a growing body of evidence that impaired clearance of apoptotic cells contributes to chronic autoimmune disease, how apoptotic cell engulfment influences cell death after acute myocardial infarction is not understood. In this issue of Circulation Research, Thorp, Yeap and their colleagues identify the MER tyrosine kinase receptor as an engulfment receptor important for the clearance of cellular debris generated during acute cardiac injury and a determining factor in infarct size, and in turn, cardiac function16.
Phagocytes in Cardiac Repair
Because of the limited regenerative capacity within the adult mammalian heart, prompt clearance of cellular debris generated during injury is necessary for activation of reparative remodeling and protection of the remaining cardiomyocytes. Infarct wound repair starts by infiltration of neutrophils and monocytes into the injured heart. These leukocytes act to clear the necrotic and apoptotic cells and degrade released intracellular contents. Using a mouse model of experimental coronary occlusion induced myocardial infarction Wan et al. show an increased expression of the phagocytic receptor MER, derived from the infiltration of phagocytic cells into the infarcted heart16.
Two distinct phases of monocyte recruitment to the injured myocardium have been appreciated. The CCR2/Ly6Chi expressing monocytes infiltrate early and have been shown to be the predominant phagocytic cell type in the infarct17. These cells respond to inflammation initially generated by injured cardiomyocytes, fibroblasts or endothelial cells18–20, as well as by the mast cells, which are poised to quickly release potent pro-inflammatory mediators, histamine and tumor necrosis factor-α21. Recruitment of inflammatory monocytes is required for the clearance of necrotic debris, as their depletion contributes to an increase in post-infarct necrotic lesions and neutrophil mediated proteolytic injury17. However, anti-inflammatory pathways are also needed, as excessive inflammation can be detrimental to the integrity of the myocardium. In the second phase of monocyte recruitment into the cardiac wound, CX3CR1/Ly6Clo monocytes stimulate angiogenesis, collagen deposition, and myofibroblast accumulation17. Both CCR2/Ly6Chi and CX3CR1/Ly6Clo monocyte subsets give rise to phagocytic macrophages17. Interestingly, Wan et al. show that MER expression is predominantly associated with the Ly6Clo monocyte subset, suggesting that MER-mediated engulfment is most likely required during the resolution phase of the inflammatory response16. The authors utilize MER deficient mice (Mertk−/−) in the coronary occlusion model to demonstrate the importance of cell clearance by the infiltrating monocytic cells. Notably, they find no obvious differences in initial monocyte numbers or the recruitment of inflammatory cells to the injured site compared to wild type mice, suggesting the importance of MER function during later stages of the inflammatory response (Figure 1)16.
Figure 1. MER tyrosine kinase deficiency leads to prolonged inflammation after myocardial infarction and increases the size of infarct.
Following myocardial infarction, monocytes and macrophages (MF) infiltrate the injury site and clear apoptotic and necrotic cardiomyocytes. Engulfment of apoptotic cells leads to production of anti-inflammatory cytokines by the phagocytes and in turn, dampening further inflammation in the cardiac tissue. In MER deficient mice, clearance of dying cardiomyocytes is delayed, resulting in prolonged inflammation and increased infarct size. After cardiac injury, ADAM17 mediated proteolytic cleavage of MER is thought to result in the appearance of the soluble MER ectodomain (solMER), which might further influence clearance and/or resolution of inflammation in the cardiac tissue.
TAMing Heart Failure
MER is a member of the TAM receptor family, which includes TYRO3, AXL, and MER tyrosine kinases22. Ablation of all three TAM receptors in mice leads to degenerative changes of the male reproductive system, the retina, and the hematopoietic system, without any apparent defect in embryonic development23. The TAM receptor triple knockout mice also develop severe systemic autoimmunity, linked to an accumulation of dying cells24, 25. Although MER is expressed in all of the affected tissues of the triple knockout mice, ablation of MER alone in the Mertk−/− mice does not have consequences as severe as those observed in the absence of the entire TAM receptor family26. Wan et al. find that MER deficiency in the Mertk−/− mice does not affect cardiac development, yet in the myocardial infarction model, MER deficiency leads to a progressive accumulation of uncleared TUNEL-positive apoptotic cardiomyocytes compared to control mice16.
Recovery from myocardial infarction requires tissue repair and suppression of inflammation27. Recognition of apoptotic cells by phagocyte receptors, including MER, triggers anti-inflammatory signaling pathways28, 29, with potent induction of IL-10 production. In fact, administration of apoptotic cell-mimicking phosphatidylserine containing liposomes to healthy rats improves infarct repair30. The impaired clearance of dying cardiomyocytes observed in Mertk−/− mice by Wan et al. is consistent with the increased levels of inflammatory cytokines in Mertk−/− hearts 7 days post infarction, along with the parallel decrease in IL-10 levels16. At the same time, failure to clear necrotic debris translates to an increase in the size of infarcted tissue and decrease in ventricle thickness of Mertk−/− mice, leading to impaired cardiac remodeling16. Because prolonged inflammation is detrimental to subsequent heart function, the authors tested cardiac function 28 days after infarction. Heart performance, as measured by systolic function, was impaired in Mertk−/− mice when compared to Mertk+/+ litermates16. Importantly, using bone marrow transfer experiments in irradiated mice, the authors further demonstrate the requirement of MER function in hematopoietic cells16. Collectively, these findings by Wan et al. suggest that MER is an important receptor that regulates cell clearance in the heart and contributes to tissue healing after cardiac injury (Figure 1).
Future Considerations
Heart failure is a major cause of morbidity and mortality, with significant efforts made toward improving the survival rates in patients with acute myocardial infarction31. Wan et al. identify MER as the engulfment receptor participating in both the clearance of dying cardiomyocytes and the generation of anti-inflammatory cues needed for cardiac remodeling of the infarcted tissue. Their findings open up a new avenue in the pursuit of therapeutic intervention aimed at improving the cardiac function after ischemic injury. One caution is that their model of permanent coronary artery occlusion does not incorporate the reperfusion phase of the recovery, which comes with its own set of risks and benefits32.
Finally, Wan et al. offer an intriguing hypothesis on the possible mechanism of MER inactivation in a natural setting. The authors demonstrate the appearance of a soluble form of MER (solMER) 5 days after the myocardial injury16. Soluble MER has been shown to inhibit macrophage clearance of apoptotic cells by acting as a decoy receptor for dying cells and, thus, preventing their engulfment by the phagocyte33. Because soluble MER is generated by ectodomain proteolysis mediated by the Adam-17 metallopeptidase34, whose expression was reported to increase in patients with acute myocardial infarction35, the possibility of therapeutic targeting of this pathway is speculated. While potentially interesting, the exact time of the appearance of soluble MER prior to or during myocardial infarction needs to be established before the possibility of prophylactic (or therapeutic) protection from MER cleavage might be considered.
Acknowledgments
Sources of Funding: This work was supported by grants to K.S.R. from the National Institutes of Health GM064709, HD074981, and MH096484.
Footnotes
Disclosures: None.
REFERENCES
- 1.Henson PM, Hume DA. Apoptotic cell removal in development and tissue homeostasis. Trends in immunology. 2006;27:244–2502. doi: 10.1016/j.it.2006.03.005. [DOI] [PubMed] [Google Scholar]
- 2.Henson PM. Dampening inflammation. Nature immunology. 2005;6:1179–1181. doi: 10.1038/ni1205-1179. [DOI] [PubMed] [Google Scholar]
- 3.Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature. 1994;372:100–103. [PubMed] [Google Scholar]
- 4.Ravichandran KS. "Recruitment signals" from apoptotic cells: Invitation to a quiet meal. Cell. 2003;113:817–820. doi: 10.1016/s0092-8674(03)00471-9. [DOI] [PubMed] [Google Scholar]
- 5.Nagata S. Apoptosis and autoimmune diseases. Annals of the New York Academy of Sciences. 2010;1209:10–16. doi: 10.1111/j.1749-6632.2010.05749.x. [DOI] [PubMed] [Google Scholar]
- 6.Aprahamian T, Takemura Y, Goukassian D, Walsh K. Ageing is associated with diminished apoptotic cell clearance in vivo. Clinical and experimental immunology. 2008;152:448–455. doi: 10.1111/j.1365-2249.2008.03658.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Li S, Sun Y, Liang CP, Thorp EB, Han S, Jehle AW, Saraswathi V, Pridgen B, Kanter JE, Li R, Welch CL, Hasty AH, Bornfeldt KE, Breslow JL, Tabas I, Tall AR. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circulation research. 2009;105:1072–1082. doi: 10.1161/CIRCRESAHA.109.199570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovascular research. 2002;53:31–47. doi: 10.1016/s0008-6363(01)00434-5. [DOI] [PubMed] [Google Scholar]
- 9.Vandivier RW, Henson PM, Douglas IS. Burying the dead: The impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. 2006;129:1673–1682. doi: 10.1378/chest.129.6.1673. [DOI] [PubMed] [Google Scholar]
- 10.Schrijvers DM, De Meyer GR, Kockx MM, Herman AG, Martinet W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2005;25:1256–1261. doi: 10.1161/01.ATV.0000166517.18801.a7. [DOI] [PubMed] [Google Scholar]
- 11.Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: The importance of lesion stage and phagocytic efficiency. Arteriosclerosis, thrombosis, and vascular biology. 2005;25:2255–2264. doi: 10.1161/01.ATV.0000184783.04864.9f. [DOI] [PubMed] [Google Scholar]
- 12.Ait-Oufella H, Kinugawa K, Zoll J, Simon T, Boddaert J, Heeneman S, Blanc-Brude O, Barateau V, Potteaux S, Merval R, Esposito B, Teissier E, Daemen MJ, Leseche G, Boulanger C, Tedgui A, Mallat Z. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation. 2007;115:2168–2177. doi: 10.1161/CIRCULATIONAHA.106.662080. [DOI] [PubMed] [Google Scholar]
- 13.Ait-Oufella H, Pouresmail V, Simon T, Blanc-Brude O, Kinugawa K, Merval R, Offenstadt G, Leseche G, Cohen PL, Tedgui A, Mallat Z. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2008;28:1429–1431. doi: 10.1161/ATVBAHA.108.169078. [DOI] [PubMed] [Google Scholar]
- 14.Boisvert WA, Rose DM, Boullier A, Quehenberger O, Sydlaske A, Johnson KA, Curtiss LK, Terkeltaub R. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arteriosclerosis, thrombosis, and vascular biology. 2006;26:563–569. doi: 10.1161/01.ATV.0000203503.82693.c1. [DOI] [PubMed] [Google Scholar]
- 15.Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe−/− mice. Arteriosclerosis, thrombosis, and vascular biology. 2008;28:1421–1428. doi: 10.1161/ATVBAHA.108.167197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wan E, Yeap XY, Dehn S, Terry RL, Novak ML, Zhang S, Iwata S, Han X, Homma S, Drosatos K, Lomasney JW, Engman DM, Miller SD, Vaughan DE, Morrow JP, Kishore R, Thorp EB. Enhanced efferocytosis of apoptotic cardiomyocytes through mer tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circulation research. 2013 doi: 10.1161/CIRCRESAHA.113.301198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. The Journal of experimental medicine. 2007;204:3037–3047. doi: 10.1084/jem.20070885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Chen W, Frangogiannis NG. Fibroblasts in post-infarction inflammation and cardiac repair. Biochimica et biophysica acta. 2013;1833:945–953. doi: 10.1016/j.bbamcr.2012.08.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Frangogiannis NG, Mendoza LH, Lewallen M, Michael LH, Smith CW, Entman ML. Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2001;15:1428–1430. doi: 10.1096/fj.00-0745fje. [DOI] [PubMed] [Google Scholar]
- 20.Palazzo AJ, Jones SP, Anderson DC, Granger DN, Lefer DJ. Coronary endothelial p-selectin in pathogenesis of myocardial ischemia-reperfusion injury. The American journal of physiology. 1998;275:H1865–H1872. doi: 10.1152/ajpheart.1998.275.5.H1865. [DOI] [PubMed] [Google Scholar]
- 21.Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH, Spengler RN, Smith CW, Entman ML. Resident cardiac mast cells degranulate and release preformed tnf-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation. 1998;98:699–710. doi: 10.1161/01.cir.98.7.699. [DOI] [PubMed] [Google Scholar]
- 22.Lemke G, Burstyn-Cohen T. Tam receptors and the clearance of apoptotic cells. Annals of the New York Academy of Sciences. 2010;1209:23–29. doi: 10.1111/j.1749-6632.2010.05744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lu Q, Gore M, Zhang Q, Camenisch T, Boast S, Casagranda F, Lai C, Skinner MK, Klein R, Matsushima GK, Earp HS, Goff SP, Lemke G. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature. 1999;398:723–728. doi: 10.1038/19554. [DOI] [PubMed] [Google Scholar]
- 24.Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the tyro 3 family. Science. 2001;293:306–311. doi: 10.1126/science.1061663. [DOI] [PubMed] [Google Scholar]
- 25.Radic MZ, Shah K, Zhang W, Lu Q, Lemke G, Hilliard GM. Heterogeneous nuclear ribonucleoprotein p2 is an autoantibody target in mice deficient for mer, axl, and tyro3 receptor tyrosine kinases. J Immunol. 2006;176:68–74. doi: 10.4049/jimmunol.176.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rahman ZS, Shao WH, Khan TN, Zhen Y, Cohen PL. Impaired apoptotic cell clearance in the germinal center by mer-deficient tingible body macrophages leads to enhanced antibody-forming cell and germinal center responses. J Immunol. 2010;185:5859–5868. doi: 10.4049/jimmunol.1001187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circulation research. 2012;110:159–173. doi: 10.1161/CIRCRESAHA.111.243162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. Tam receptors are pleiotropic inhibitors of the innate immune response. Cell. 2007;131:1124–1136. doi: 10.1016/j.cell.2007.10.034. [DOI] [PubMed] [Google Scholar]
- 29.Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature. 1997;390:350–351. doi: 10.1038/37022. [DOI] [PubMed] [Google Scholar]
- 30.Harel-Adar T, Ben Mordechai T, Amsalem Y, Feinberg MS, Leor J, Cohen S. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proceedings of the National Academy of Sciences of the United States of America. 2011;108:1827–1832. doi: 10.1073/pnas.1015623108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Parikh NI, Gona P, Larson MG, Fox CS, Benjamin EJ, Murabito JM, O'Donnell CJ, Vasan RS, Levy D. Long-term trends in myocardial infarction incidence and case fatality in the national heart, lung, and blood institute's framingham heart study. Circulation. 2009;119:1203–1210. doi: 10.1161/CIRCULATIONAHA.108.825364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Braunwald E, Kloner RA. Myocardial reperfusion: A double-edged sword? The Journal of clinical investigation. 1985;76:1713–1719. doi: 10.1172/JCI112160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum BC, Henson PM, Graham DK. A soluble form of the mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood. 2007;109:1026–1033. doi: 10.1182/blood-2006-05-021634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Thorp E, Vaisar T, Subramanian M, Mautner L, Blobel C, Tabas I. Shedding of the mer tyrosine kinase receptor is mediated by adam17 protein through a pathway involving reactive oxygen species, protein kinase cdelta, and p38 mitogen-activated protein kinase (mapk) The Journal of biological chemistry. 2011;286:33335–33344. doi: 10.1074/jbc.M111.263020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Akatsu T, Nakamura M, Satoh M, Hiramori K. Increased mrna expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction. Clin Sci (Lond) 2003;105:39–44. doi: 10.1042/CS20020367. [DOI] [PubMed] [Google Scholar]

